View ValuationGr. Sarantis 향후 성장Future 기준 점검 1/6Gr. Sarantis (는) 각각 연간 9.7% 및 4.5% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 10% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 14.3% 로 예상됩니다.핵심 정보9.7%이익 성장률10.00%EPS 성장률Personal Products 이익 성장8.5%매출 성장률4.5%향후 자기자본이익률14.30%애널리스트 커버리지Low마지막 업데이트24 Mar 2026최근 향후 성장 업데이트공시 • Sep 06Gr. Sarantis S.A. Not to Provide Financial Guidance for the Fiscal Year of 2020Gr. Sarantis S.A. is not provide financial guidance for the fiscal year of 2020 as it is not able to make accurate predictions at the time due to the continuing high uncertainty regarding the impact of COVID-19 on the economy, the consumption and the disposable income.모든 업데이트 보기Recent updatesBoard Change • May 20High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. Executive Chairman Kyriakos Sarantis was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.공시 • Mar 13Gr. Sarantis S.A. announces Annual dividend, payable on May 08, 2026Gr. Sarantis S.A. announced Annual dividend of EUR 0.3925 per share payable on May 08, 2026, ex-date on May 04, 2026 and record date on May 05, 2026.공시 • Jan 15+ 2 more updatesGr. Sarantis S.A. to Report Fiscal Year 2025 Results on Mar 11, 2026Gr. Sarantis S.A. announced that they will report fiscal year 2025 results on Mar 11, 2026공시 • Mar 13Gr. Sarantis S.A. announces Annual dividend, payable on May 09, 2025Gr. Sarantis S.A. announced Annual dividend of EUR 0.2992 per share payable on May 09, 2025, ex-date on May 02, 2025 and record date on May 05, 2025.공시 • Feb 19Gr. Sarantis S.A. to Report Fiscal Year 2024 Results on Mar 12, 2025Gr. Sarantis S.A. announced that they will report fiscal year 2024 results After-Market on Mar 12, 2025공시 • Feb 04Gr. Sarantis S.A., Annual General Meeting, Apr 28, 2025Gr. Sarantis S.A., Annual General Meeting, Apr 28, 2025.Recent Insider Transactions • Sep 26Executive Chairman recently bought €544k worth of stockOn the 23rd of September, Kyriakos Sarantis bought around 50k shares on-market at roughly €10.88 per share. This transaction amounted to 1.3% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €6.1m worth in shares.Reported Earnings • Sep 06First half 2024 earnings released: EPS: €0.38 (vs €0.29 in 1H 2023)First half 2024 results: EPS: €0.38 (up from €0.29 in 1H 2023). Revenue: €302.6m (up 30% from 1H 2023). Net income: €24.3m (up 27% from 1H 2023). Profit margin: 8.0% (down from 8.3% in 1H 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.8% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 6% per year.Buy Or Sell Opportunity • Jul 22Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 5.7% to €10.88. The fair value is estimated to be €13.69, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last 3 years. Earnings per share has declined by 2.7%. For the next 3 years, revenue is forecast to grow by 7.2% per annum. Earnings are also forecast to grow by 13% per annum over the same time period.Recent Insider Transactions • Jul 10Executive Chairman recently bought €110k worth of stockOn the 4th of July, Kyriakos Sarantis bought around 10k shares on-market at roughly €11.00 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €6.0m worth in shares.Buy Or Sell Opportunity • Jul 01Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 9.9% to €10.68. The fair value is estimated to be €13.45, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last 3 years. Earnings per share has declined by 2.7%. For the next 3 years, revenue is forecast to grow by 7.2% per annum. Earnings are also forecast to grow by 13% per annum over the same time period.Buy Or Sell Opportunity • Jun 12Now 21% undervaluedOver the last 90 days, the stock has risen 4.8% to €10.98. The fair value is estimated to be €13.92, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last 3 years. Earnings per share has declined by 2.7%. For the next 3 years, revenue is forecast to grow by 7.5% per annum. Earnings are also forecast to grow by 12% per annum over the same time period.Declared Dividend • Apr 26Dividend increased to €0.22Dividend of €0.22 is 50% higher than last year. Ex-date: 2nd May 2024 Payment date: 13th May 2024 Dividend yield will be 1.9%, which is about the same as the industry average. Sustainability & Growth Dividend is well covered by both earnings (38% earnings payout ratio) and cash flows (28% cash payout ratio). The dividend has increased by an average of 4.1% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 38% over the next 3 years, which should provide support to the dividend and adequate earnings cover.공시 • Mar 30+ 1 more updateGr. Sarantis S.A. to Report First Half, 2024 Results on Sep 03, 2024Gr. Sarantis S.A. announced that they will report first half, 2024 results on Sep 03, 2024Valuation Update With 7 Day Price Move • Mar 18Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €11.00, the stock trades at a trailing P/E ratio of 19.4x. Average forward P/E is 20x in the Personal Products industry in Europe. Total returns to shareholders of 36% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €7.96 per share.Buy Or Sell Opportunity • Mar 12Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 21% to €9.62. The fair value is estimated to be €7.92, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last 3 years. Earnings per share has declined by 2.7%.Reported Earnings • Mar 12Full year 2023 earnings released: EPS: €0.59 (vs €0.39 in FY 2022)Full year 2023 results: EPS: €0.59 (up from €0.39 in FY 2022). Revenue: €482.2m (up 8.3% from FY 2022). Net income: €39.3m (up 50% from FY 2022). Profit margin: 8.2% (up from 5.9% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 5.3% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has increased by 2% per year.공시 • Mar 01Gr. Sarantis S.A. to Report Fiscal Year 2023 Results on Mar 11, 2024Gr. Sarantis S.A. announced that they will report fiscal year 2023 results on Mar 11, 2024공시 • Dec 01Gr. Sarantis S.A., Annual General Meeting, Dec 20, 2023Gr. Sarantis S.A., Annual General Meeting, Dec 20, 2023, at 15:00 E. Europe Standard Time. Location: 26 AMAROUSSIOU-HALANDRIOU STR. 151 25 MAROUSI Marousi Greece공시 • Nov 01Gr. Sarantis S.A. to Report Nine Months, 2023 Results on Nov 07, 2023Gr. Sarantis S.A. announced that they will report nine months, 2023 results on Nov 07, 2023New Risk • Oct 26New major risk - Revenue and earnings growthEarnings have declined by 2.2% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.2% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Shareholders have been diluted in the past year (3.7% increase in shares outstanding).Reported Earnings • Sep 14First half 2023 earnings released: EPS: €0.29 (vs €0.17 in 1H 2022)First half 2023 results: EPS: €0.29 (up from €0.17 in 1H 2022). Revenue: €232.4m (up 9.2% from 1H 2022). Net income: €19.2m (up 66% from 1H 2022). Profit margin: 8.3% (up from 5.4% in 1H 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 5.1% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.공시 • Aug 29Gr. Sarantis S.A. to Report First Half, 2023 Results on Sep 11, 2023Gr. Sarantis S.A. announced that they will report first half, 2023 results on Sep 11, 2023New Risk • Aug 09New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 4.4% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Shareholders have been diluted in the past year (4.4% increase in shares outstanding).Reported Earnings • Mar 29Full year 2022 earnings releasedFull year 2022 results: Revenue: €445.1m (up 9.0% from FY 2021). Net income: €26.3m (down 35% from FY 2021). Profit margin: 5.9% (down from 9.9% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 4.8% growth forecast for the Personal Products industry in Europe.Board Change • Nov 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 10 experienced directors. No highly experienced directors. 4 independent directors (7 non-independent directors). Independent Non-Executive Director Nikos Nomikos was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Sep 11First half 2022 earnings released: EPS: €0.17 (vs €0.22 in 1H 2021)First half 2022 results: EPS: €0.17 (down from €0.22 in 1H 2021). Revenue: €213.5m (up 9.3% from 1H 2021). Net income: €11.6m (down 21% from 1H 2021). Profit margin: 5.4% (down from 7.5% in 1H 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.공시 • Aug 25Gr. Sarantis S.A. to Report First Half, 2022 Results on Sep 08, 2022Gr. Sarantis S.A. announced that they will report first half, 2022 results on Sep 08, 2022Reported Earnings • May 05Full year 2021 earnings released: EPS: €0.60 (vs €0.58 in FY 2020)Full year 2021 results: EPS: €0.60 (up from €0.58 in FY 2020). Revenue: €408.2m (up 3.8% from FY 2020). Net income: €40.3m (up 4.0% from FY 2020). Profit margin: 9.9% (in line with FY 2020). Over the next year, revenue is forecast to grow 9.0%, compared to a 12% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. No highly experienced directors. 4 independent directors (7 non-independent directors). Independent Non-Executive Director Nikos Nomikos was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.공시 • Apr 12Gr. Sarantis S.A., Annual General Meeting, May 24, 2022Gr. Sarantis S.A., Annual General Meeting, May 24, 2022.공시 • Apr 05Gr. Sarantis S.A. to Report Fiscal Year 2021 Results on Apr 29, 2022Gr. Sarantis S.A. announced that they will report fiscal year 2021 results on Apr 29, 2022Recent Insider Transactions • Mar 30CEO & Director recently sold €2.0m worth of stockOn the 23rd of March, Kyriakos Sarantis sold around 265k shares on-market at roughly €7.50 per share. This was the largest sale by an insider in the last 3 months. Despite the recent sale, Kyriakos has been a buyer over the last 12 months, purchasing a net total of €2.2m worth of shares.Valuation Update With 7 Day Price Move • Mar 15Investor sentiment improved over the past weekAfter last week's 15% share price gain to €7.35, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 27x in the Personal Products industry in Europe. Total returns to shareholders of 12% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €14.65 per share.Valuation Update With 7 Day Price Move • Feb 26Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to €7.01, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 28x in the Personal Products industry in Europe. Total returns to shareholders of 3.8% over the past three years.Board Change • Jan 28Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. No highly experienced directors. 4 independent directors (7 non-independent directors). Independent Non-Executive Director Nikos Nomikos was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Recent Insider Transactions • Dec 10Vice Chairman & CEO recently bought €86k worth of stockOn the 1st of December, Kyriakos Sarantis bought around 10k shares on-market at roughly €8.61 per share. In the last 3 months, they made an even bigger purchase worth €248k. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €4.4m worth in shares.공시 • Dec 05Gr. Sarantis S.A. (ATSE:SAR) announces an Equity Buyback for 4,222,844 shares, representing 6.04% for €63.34 million.Gr. Sarantis S.A. (ATSE:SAR) commences share repurchases on December 2, 2021, under the program mandated by the shareholders in the Extraordinary Shareholders Meeting held on September 2, 2020. As per the mandate, the company is authorized to repurchase up to 4,222,844 shares representing 6.04% of the company's outstanding shares after excluding treasury shares for a total of €63.34 million. The maximum buy back price will be at €15 per share and the minimum is €0.78 per share. The purpose of the program is to serve the objectives and uses permitted by law from time to time, which today include share capital reduction, settlement of obligations arising by convertible securities or employee stock options as well as the purposes of future acquisition of another company’s shares. The repurchase program will be valid for 24 months, until September 2, 2022.Recent Insider Transactions • Nov 10Vice Chairman & CEO recently bought €119k worth of stockOn the 5th of November, Kyriakos Sarantis bought around 14k shares on-market at roughly €8.63 per share. In the last 3 months, they made an even bigger purchase worth €248k. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €4.2m worth in shares.Recent Insider Transactions • Oct 27Vice Chairman & CEO recently bought €248k worth of stockOn the 20th of October, Kyriakos Sarantis bought around 28k shares on-market at roughly €8.78 per share. This was the largest purchase by an insider in the last 3 months. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €4.0m worth in shares.Reported Earnings • Sep 11First half 2021 earnings released: EPS €0.29 (vs €0.23 in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €195.2m (up 6.3% from 1H 2020). Net income: €19.5m (up 25% from 1H 2020). Profit margin: 10.0% (up from 8.5% in 1H 2020). Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 8% per year.Recent Insider Transactions • Jul 15Vice Chairman & CEO recently bought €61k worth of stockOn the 8th of July, Kyriakos Sarantis bought around 7k shares on-market at roughly €8.78 per share. In the last 3 months, they made an even bigger purchase worth €915k. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €3.2m worth in shares.Recent Insider Transactions • Jun 12Vice Chairman & CEO recently bought €90k worth of stockOn the 7th of June, Kyriakos Sarantis bought around 10k shares on-market at roughly €8.80 per share. In the last 3 months, they made an even bigger purchase worth €915k. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €3.2m worth in shares.Recent Insider Transactions • Jun 02Vice Chairman & CEO recently bought €915k worth of stockOn the 26th of May, Kyriakos Sarantis bought around 105k shares on-market at roughly €8.71 per share. This was the largest purchase by an insider in the last 3 months. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €2.8m worth in shares.Recent Insider Transactions • May 23Vice Chairman & CEO recently bought €69k worth of stockOn the 18th of May, Kyriakos Sarantis bought around 8k shares on-market at roughly €8.75 per share. In the last 3 months, they made an even bigger purchase worth €217k. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €2.0m worth in shares.Recent Insider Transactions • May 08Vice Chairman & CEO recently bought €217k worth of stockOn the 5th of May, Kyriakos Sarantis bought around 24k shares on-market at roughly €8.88 per share. This was the largest purchase by an insider in the last 3 months. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €1.6m worth in shares.Reported Earnings • Apr 11Full year 2020 earnings released: EPS €0.58 (vs €0.57 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: €393.4m (up 6.3% from FY 2019). Net income: €38.7m (up 1.9% from FY 2019). Profit margin: 9.8% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.공시 • Mar 06Gr. Sarantis S.A. to Report Fiscal Year 2020 Results on Apr 08, 2021Gr. Sarantis S.A. announced that they will report fiscal year 2020 results After-Market on Apr 08, 2021Recent Insider Transactions • Mar 05Vice Chairman & CEO recently bought €96k worth of stockOn the 25th of February, Kyriakos Sarantis bought around 11k shares on-market at roughly €9.05 per share. In the last 3 months, they made an even bigger purchase worth €118k. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €1.3m worth in shares.Recent Insider Transactions • Feb 13Vice Chairman & CEO recently bought €118k worth of stockOn the 5th of February, Kyriakos Sarantis bought around 13k shares on-market at roughly €8.85 per share. This was the largest purchase by an insider in the last 3 months. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €1.2m worth in shares.Is New 90 Day High Low • Jan 05New 90-day high: €9.27The company is up 5.0% from its price of €8.84 on 07 October 2020. The German market is up 8.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Personal Products industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €6.26 per share.Recent Insider Transactions • Dec 16Vice Chairman & CEO recently bought €51k worth of stockOn the 10th of December, Kyriakos Sarantis bought around 6k shares on-market at roughly €8.74 per share. In the last 3 months, they made an even bigger purchase worth €69k. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €474k worth in shares.공시 • Sep 22Mehmet Yigit Sardan will acquire 15% interest in Sarantis Anadol from Sarantis.Mehmet Yigit Sardan will acquire 15% interest in Sarantis Anadol from Sarantis on September 28, 2006.공시 • Sep 06Gr. Sarantis S.A. Not to Provide Financial Guidance for the Fiscal Year of 2020Gr. Sarantis S.A. is not provide financial guidance for the fiscal year of 2020 as it is not able to make accurate predictions at the time due to the continuing high uncertainty regarding the impact of COVID-19 on the economy, the consumption and the disposable income.공시 • Aug 03Gr. Sarantis S.A. to Report First Half, 2020 Results on Sep 02, 2020Gr. Sarantis S.A. announced that they will report first half, 2020 results on Sep 02, 2020이익 및 매출 성장 예측DB:SSA1 - 애널리스트 향후 추정치 및 과거 재무 데이터 (EUR Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/2028692719793412/31/2027661657390412/31/2026626595683412/31/2025600534077N/A9/30/2025601523266N/A6/30/2025602512455N/A3/31/2025601483458N/A12/31/2024600464462N/A9/30/2024576454660N/A6/30/2024552444758N/A3/31/2024517425059N/A12/31/2023482395259N/A9/30/2023473374552N/A6/30/2023465343745N/A3/31/2023455302534N/A12/31/2022445261223N/A9/30/2022434271025N/A6/30/202242428828N/A3/31/2022415291439N/A12/31/2021406312050N/A9/30/2021406341342N/A6/30/202140538533N/A3/31/202139938532N/A12/31/202039339432N/A9/30/202038739834N/A6/30/2020382401236N/A3/31/202037639928N/A12/31/201937038620N/A9/30/201936336N/A15N/A6/30/201935634N/A11N/A3/31/201935033N/A11N/A12/31/201834433N/A11N/A9/30/201832930N/A15N/A6/30/201831427N/A20N/A3/31/201830728N/A24N/A12/31/201730029N/A28N/A9/30/201730829N/A22N/A6/30/201731529N/A15N/A3/31/201732227N/A13N/A12/31/201632925N/A10N/A9/30/201632325N/A11N/A6/30/201630623N/A12N/A3/31/201630322N/A12N/A12/31/201527920N/A12N/A9/30/201526619N/A14N/A6/30/201526017N/A15N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: SSA1 의 연간 예상 수익 증가율(9.7%)이 saving rate(1.9%)보다 높습니다.수익 vs 시장: SSA1 의 연간 수익(9.7%)이 German 시장(17.1%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: SSA1 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: SSA1 의 수익(연간 4.5%)이 German 시장(연간 6.8%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: SSA1 의 수익(연간 4.5%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: SSA1의 자본 수익률은 3년 후 14.3%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YHousehold 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 12:20종가2026/05/22 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Gr. Sarantis S.A.는 12명의 분석가가 다루고 있습니다. 이 중 5명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Manos ChatzidakisBeta Securities S.A.Dimitris GiannoulisDeutsche BankNatalia Svyrou SvyriadiEurobank Equities Investment Firm S.A.9명의 분석가 더 보기
공시 • Sep 06Gr. Sarantis S.A. Not to Provide Financial Guidance for the Fiscal Year of 2020Gr. Sarantis S.A. is not provide financial guidance for the fiscal year of 2020 as it is not able to make accurate predictions at the time due to the continuing high uncertainty regarding the impact of COVID-19 on the economy, the consumption and the disposable income.
Board Change • May 20High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. Executive Chairman Kyriakos Sarantis was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
공시 • Mar 13Gr. Sarantis S.A. announces Annual dividend, payable on May 08, 2026Gr. Sarantis S.A. announced Annual dividend of EUR 0.3925 per share payable on May 08, 2026, ex-date on May 04, 2026 and record date on May 05, 2026.
공시 • Jan 15+ 2 more updatesGr. Sarantis S.A. to Report Fiscal Year 2025 Results on Mar 11, 2026Gr. Sarantis S.A. announced that they will report fiscal year 2025 results on Mar 11, 2026
공시 • Mar 13Gr. Sarantis S.A. announces Annual dividend, payable on May 09, 2025Gr. Sarantis S.A. announced Annual dividend of EUR 0.2992 per share payable on May 09, 2025, ex-date on May 02, 2025 and record date on May 05, 2025.
공시 • Feb 19Gr. Sarantis S.A. to Report Fiscal Year 2024 Results on Mar 12, 2025Gr. Sarantis S.A. announced that they will report fiscal year 2024 results After-Market on Mar 12, 2025
공시 • Feb 04Gr. Sarantis S.A., Annual General Meeting, Apr 28, 2025Gr. Sarantis S.A., Annual General Meeting, Apr 28, 2025.
Recent Insider Transactions • Sep 26Executive Chairman recently bought €544k worth of stockOn the 23rd of September, Kyriakos Sarantis bought around 50k shares on-market at roughly €10.88 per share. This transaction amounted to 1.3% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €6.1m worth in shares.
Reported Earnings • Sep 06First half 2024 earnings released: EPS: €0.38 (vs €0.29 in 1H 2023)First half 2024 results: EPS: €0.38 (up from €0.29 in 1H 2023). Revenue: €302.6m (up 30% from 1H 2023). Net income: €24.3m (up 27% from 1H 2023). Profit margin: 8.0% (down from 8.3% in 1H 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.8% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 6% per year.
Buy Or Sell Opportunity • Jul 22Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 5.7% to €10.88. The fair value is estimated to be €13.69, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last 3 years. Earnings per share has declined by 2.7%. For the next 3 years, revenue is forecast to grow by 7.2% per annum. Earnings are also forecast to grow by 13% per annum over the same time period.
Recent Insider Transactions • Jul 10Executive Chairman recently bought €110k worth of stockOn the 4th of July, Kyriakos Sarantis bought around 10k shares on-market at roughly €11.00 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €6.0m worth in shares.
Buy Or Sell Opportunity • Jul 01Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 9.9% to €10.68. The fair value is estimated to be €13.45, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last 3 years. Earnings per share has declined by 2.7%. For the next 3 years, revenue is forecast to grow by 7.2% per annum. Earnings are also forecast to grow by 13% per annum over the same time period.
Buy Or Sell Opportunity • Jun 12Now 21% undervaluedOver the last 90 days, the stock has risen 4.8% to €10.98. The fair value is estimated to be €13.92, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last 3 years. Earnings per share has declined by 2.7%. For the next 3 years, revenue is forecast to grow by 7.5% per annum. Earnings are also forecast to grow by 12% per annum over the same time period.
Declared Dividend • Apr 26Dividend increased to €0.22Dividend of €0.22 is 50% higher than last year. Ex-date: 2nd May 2024 Payment date: 13th May 2024 Dividend yield will be 1.9%, which is about the same as the industry average. Sustainability & Growth Dividend is well covered by both earnings (38% earnings payout ratio) and cash flows (28% cash payout ratio). The dividend has increased by an average of 4.1% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 38% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
공시 • Mar 30+ 1 more updateGr. Sarantis S.A. to Report First Half, 2024 Results on Sep 03, 2024Gr. Sarantis S.A. announced that they will report first half, 2024 results on Sep 03, 2024
Valuation Update With 7 Day Price Move • Mar 18Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €11.00, the stock trades at a trailing P/E ratio of 19.4x. Average forward P/E is 20x in the Personal Products industry in Europe. Total returns to shareholders of 36% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €7.96 per share.
Buy Or Sell Opportunity • Mar 12Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 21% to €9.62. The fair value is estimated to be €7.92, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last 3 years. Earnings per share has declined by 2.7%.
Reported Earnings • Mar 12Full year 2023 earnings released: EPS: €0.59 (vs €0.39 in FY 2022)Full year 2023 results: EPS: €0.59 (up from €0.39 in FY 2022). Revenue: €482.2m (up 8.3% from FY 2022). Net income: €39.3m (up 50% from FY 2022). Profit margin: 8.2% (up from 5.9% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 5.3% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has increased by 2% per year.
공시 • Mar 01Gr. Sarantis S.A. to Report Fiscal Year 2023 Results on Mar 11, 2024Gr. Sarantis S.A. announced that they will report fiscal year 2023 results on Mar 11, 2024
공시 • Dec 01Gr. Sarantis S.A., Annual General Meeting, Dec 20, 2023Gr. Sarantis S.A., Annual General Meeting, Dec 20, 2023, at 15:00 E. Europe Standard Time. Location: 26 AMAROUSSIOU-HALANDRIOU STR. 151 25 MAROUSI Marousi Greece
공시 • Nov 01Gr. Sarantis S.A. to Report Nine Months, 2023 Results on Nov 07, 2023Gr. Sarantis S.A. announced that they will report nine months, 2023 results on Nov 07, 2023
New Risk • Oct 26New major risk - Revenue and earnings growthEarnings have declined by 2.2% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 2.2% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Shareholders have been diluted in the past year (3.7% increase in shares outstanding).
Reported Earnings • Sep 14First half 2023 earnings released: EPS: €0.29 (vs €0.17 in 1H 2022)First half 2023 results: EPS: €0.29 (up from €0.17 in 1H 2022). Revenue: €232.4m (up 9.2% from 1H 2022). Net income: €19.2m (up 66% from 1H 2022). Profit margin: 8.3% (up from 5.4% in 1H 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 5.1% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
공시 • Aug 29Gr. Sarantis S.A. to Report First Half, 2023 Results on Sep 11, 2023Gr. Sarantis S.A. announced that they will report first half, 2023 results on Sep 11, 2023
New Risk • Aug 09New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 4.4% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Shareholders have been diluted in the past year (4.4% increase in shares outstanding).
Reported Earnings • Mar 29Full year 2022 earnings releasedFull year 2022 results: Revenue: €445.1m (up 9.0% from FY 2021). Net income: €26.3m (down 35% from FY 2021). Profit margin: 5.9% (down from 9.9% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 4.8% growth forecast for the Personal Products industry in Europe.
Board Change • Nov 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 10 experienced directors. No highly experienced directors. 4 independent directors (7 non-independent directors). Independent Non-Executive Director Nikos Nomikos was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Sep 11First half 2022 earnings released: EPS: €0.17 (vs €0.22 in 1H 2021)First half 2022 results: EPS: €0.17 (down from €0.22 in 1H 2021). Revenue: €213.5m (up 9.3% from 1H 2021). Net income: €11.6m (down 21% from 1H 2021). Profit margin: 5.4% (down from 7.5% in 1H 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
공시 • Aug 25Gr. Sarantis S.A. to Report First Half, 2022 Results on Sep 08, 2022Gr. Sarantis S.A. announced that they will report first half, 2022 results on Sep 08, 2022
Reported Earnings • May 05Full year 2021 earnings released: EPS: €0.60 (vs €0.58 in FY 2020)Full year 2021 results: EPS: €0.60 (up from €0.58 in FY 2020). Revenue: €408.2m (up 3.8% from FY 2020). Net income: €40.3m (up 4.0% from FY 2020). Profit margin: 9.9% (in line with FY 2020). Over the next year, revenue is forecast to grow 9.0%, compared to a 12% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. No highly experienced directors. 4 independent directors (7 non-independent directors). Independent Non-Executive Director Nikos Nomikos was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
공시 • Apr 12Gr. Sarantis S.A., Annual General Meeting, May 24, 2022Gr. Sarantis S.A., Annual General Meeting, May 24, 2022.
공시 • Apr 05Gr. Sarantis S.A. to Report Fiscal Year 2021 Results on Apr 29, 2022Gr. Sarantis S.A. announced that they will report fiscal year 2021 results on Apr 29, 2022
Recent Insider Transactions • Mar 30CEO & Director recently sold €2.0m worth of stockOn the 23rd of March, Kyriakos Sarantis sold around 265k shares on-market at roughly €7.50 per share. This was the largest sale by an insider in the last 3 months. Despite the recent sale, Kyriakos has been a buyer over the last 12 months, purchasing a net total of €2.2m worth of shares.
Valuation Update With 7 Day Price Move • Mar 15Investor sentiment improved over the past weekAfter last week's 15% share price gain to €7.35, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 27x in the Personal Products industry in Europe. Total returns to shareholders of 12% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €14.65 per share.
Valuation Update With 7 Day Price Move • Feb 26Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to €7.01, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 28x in the Personal Products industry in Europe. Total returns to shareholders of 3.8% over the past three years.
Board Change • Jan 28Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. No highly experienced directors. 4 independent directors (7 non-independent directors). Independent Non-Executive Director Nikos Nomikos was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Recent Insider Transactions • Dec 10Vice Chairman & CEO recently bought €86k worth of stockOn the 1st of December, Kyriakos Sarantis bought around 10k shares on-market at roughly €8.61 per share. In the last 3 months, they made an even bigger purchase worth €248k. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €4.4m worth in shares.
공시 • Dec 05Gr. Sarantis S.A. (ATSE:SAR) announces an Equity Buyback for 4,222,844 shares, representing 6.04% for €63.34 million.Gr. Sarantis S.A. (ATSE:SAR) commences share repurchases on December 2, 2021, under the program mandated by the shareholders in the Extraordinary Shareholders Meeting held on September 2, 2020. As per the mandate, the company is authorized to repurchase up to 4,222,844 shares representing 6.04% of the company's outstanding shares after excluding treasury shares for a total of €63.34 million. The maximum buy back price will be at €15 per share and the minimum is €0.78 per share. The purpose of the program is to serve the objectives and uses permitted by law from time to time, which today include share capital reduction, settlement of obligations arising by convertible securities or employee stock options as well as the purposes of future acquisition of another company’s shares. The repurchase program will be valid for 24 months, until September 2, 2022.
Recent Insider Transactions • Nov 10Vice Chairman & CEO recently bought €119k worth of stockOn the 5th of November, Kyriakos Sarantis bought around 14k shares on-market at roughly €8.63 per share. In the last 3 months, they made an even bigger purchase worth €248k. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €4.2m worth in shares.
Recent Insider Transactions • Oct 27Vice Chairman & CEO recently bought €248k worth of stockOn the 20th of October, Kyriakos Sarantis bought around 28k shares on-market at roughly €8.78 per share. This was the largest purchase by an insider in the last 3 months. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €4.0m worth in shares.
Reported Earnings • Sep 11First half 2021 earnings released: EPS €0.29 (vs €0.23 in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: €195.2m (up 6.3% from 1H 2020). Net income: €19.5m (up 25% from 1H 2020). Profit margin: 10.0% (up from 8.5% in 1H 2020). Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 8% per year.
Recent Insider Transactions • Jul 15Vice Chairman & CEO recently bought €61k worth of stockOn the 8th of July, Kyriakos Sarantis bought around 7k shares on-market at roughly €8.78 per share. In the last 3 months, they made an even bigger purchase worth €915k. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €3.2m worth in shares.
Recent Insider Transactions • Jun 12Vice Chairman & CEO recently bought €90k worth of stockOn the 7th of June, Kyriakos Sarantis bought around 10k shares on-market at roughly €8.80 per share. In the last 3 months, they made an even bigger purchase worth €915k. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €3.2m worth in shares.
Recent Insider Transactions • Jun 02Vice Chairman & CEO recently bought €915k worth of stockOn the 26th of May, Kyriakos Sarantis bought around 105k shares on-market at roughly €8.71 per share. This was the largest purchase by an insider in the last 3 months. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €2.8m worth in shares.
Recent Insider Transactions • May 23Vice Chairman & CEO recently bought €69k worth of stockOn the 18th of May, Kyriakos Sarantis bought around 8k shares on-market at roughly €8.75 per share. In the last 3 months, they made an even bigger purchase worth €217k. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €2.0m worth in shares.
Recent Insider Transactions • May 08Vice Chairman & CEO recently bought €217k worth of stockOn the 5th of May, Kyriakos Sarantis bought around 24k shares on-market at roughly €8.88 per share. This was the largest purchase by an insider in the last 3 months. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €1.6m worth in shares.
Reported Earnings • Apr 11Full year 2020 earnings released: EPS €0.58 (vs €0.57 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: €393.4m (up 6.3% from FY 2019). Net income: €38.7m (up 1.9% from FY 2019). Profit margin: 9.8% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.
공시 • Mar 06Gr. Sarantis S.A. to Report Fiscal Year 2020 Results on Apr 08, 2021Gr. Sarantis S.A. announced that they will report fiscal year 2020 results After-Market on Apr 08, 2021
Recent Insider Transactions • Mar 05Vice Chairman & CEO recently bought €96k worth of stockOn the 25th of February, Kyriakos Sarantis bought around 11k shares on-market at roughly €9.05 per share. In the last 3 months, they made an even bigger purchase worth €118k. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €1.3m worth in shares.
Recent Insider Transactions • Feb 13Vice Chairman & CEO recently bought €118k worth of stockOn the 5th of February, Kyriakos Sarantis bought around 13k shares on-market at roughly €8.85 per share. This was the largest purchase by an insider in the last 3 months. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €1.2m worth in shares.
Is New 90 Day High Low • Jan 05New 90-day high: €9.27The company is up 5.0% from its price of €8.84 on 07 October 2020. The German market is up 8.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Personal Products industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €6.26 per share.
Recent Insider Transactions • Dec 16Vice Chairman & CEO recently bought €51k worth of stockOn the 10th of December, Kyriakos Sarantis bought around 6k shares on-market at roughly €8.74 per share. In the last 3 months, they made an even bigger purchase worth €69k. Kyriakos has been a buyer over the last 12 months, purchasing a net total of €474k worth in shares.
공시 • Sep 22Mehmet Yigit Sardan will acquire 15% interest in Sarantis Anadol from Sarantis.Mehmet Yigit Sardan will acquire 15% interest in Sarantis Anadol from Sarantis on September 28, 2006.
공시 • Sep 06Gr. Sarantis S.A. Not to Provide Financial Guidance for the Fiscal Year of 2020Gr. Sarantis S.A. is not provide financial guidance for the fiscal year of 2020 as it is not able to make accurate predictions at the time due to the continuing high uncertainty regarding the impact of COVID-19 on the economy, the consumption and the disposable income.
공시 • Aug 03Gr. Sarantis S.A. to Report First Half, 2020 Results on Sep 02, 2020Gr. Sarantis S.A. announced that they will report first half, 2020 results on Sep 02, 2020